1. Reduced midbrain raphe echogenicity in patients with fibromyalgia syndrome
- Author
-
Nurcan Üçeyler, Mira Schließer, Dimitar Evdokimov, Jakub Radziwon, Betty Feulner, Stefan Unterecker, Florian Rimmele, and Uwe Walter
- Subjects
Male ,Multidisciplinary ,Fibromyalgia ,Midbrain Raphe Nuclei ,Humans ,Raphe Nuclei ,Pain ,Female ,ddc:610 ,Ultrasonography - Abstract
Objectives The pathogenesis of fibromyalgia syndrome (FMS) is unclear. Transcranial ultrasonography revealed anechoic alteration of midbrain raphe in depression and anxiety disorders, suggesting affection of the central serotonergic system. Here, we assessed midbrain raphe echogenicity in FMS. Methods Sixty-six patients underwent transcranial sonography, of whom 53 were patients with FMS (27 women, 26 men), 13 patients with major depression and physical pain (all women), and 14 healthy controls (11 women, 3 men). Raphe echogenicity was graded visually as normal or hypoechogenic, and quantified by digitized image analysis, each by investigators blinded to the clinical diagnosis. Results Quantitative midbrain raphe echogenicity was lower in patients with FMS compared to healthy controls (p Conclusion We found reduced echogenicity of the midbrain raphe area in patients with FMS and in patients with depression and physical pain, independent of the presence or severity of pain, FMS, and depressive symptoms. Further exploration of this sonographic finding is necessary before this objective technique may enter diagnostic algorithms in FMS and depression.
- Published
- 2022